Translating Clinical Trial Evidence into a Payer-Relevant Value Narrative
- Client had evidence from three trials but lacked a unified story across clinical, statistical, and payer audiences.
- Existing trial endpoints did not directly connect to reimbursement and economic value measures.
- Reviewed and organized data room materials across three studies.
- Built a clinical and biostatistical narrative based on evidence strength and relevance.
- Supported HCP engagement and evidence validation.
- Created charts, diagrams, and modality visuals for cross-stakeholder communication.
- Built a crosswalk from trial endpoints to EQ-5D, then to QALYs and ICER for payer relevant claims.
- Unified fragmented evidence into a coherent stakeholder-ready narrative.
- Created a novel bridge from clinical outcomes to payer value measures.
- Strengthened support for reimbursement and cost-effectiveness discussions.
